Document:

ex_159804.htm

Exhibit 10.1

 

 

SECOND AMENDMENT TO 

LICENSE AGREEMENT NO. A9672

 

 

WHEREAS, the University of Florida Research Foundation, Inc., a not-for-profit corporation duly organized and existing under the laws of the State of Florida and having its principal office at 223 Grinter Hall, Gainesville, Florida 32611 U.S.A. (hereinafter referred to as “UFRF”), and Sun BioPharma, Inc., a Delaware corporation, and having its principal mailing address at 712 Vista Blvd, #305, Waconia, MN 55387, (hereinafter referred to as “Licensee”) entered into a License Agreement effective December 22, 2011 (hereinafter “License Agreement”);

 

WHEREAS the parties entered into a “First Amendment to License Agreement N0. A9672” effective December 12, 2016;

 

WHEREAS the parties now wish to further amend the License Agreement;

 

NOW THEREFORE, in consideration of the premises and mutual covenants contained herein the parties hereto agree as follows;

 

 

	
			1.

				
			In Section 2.2.2 of the License Agreement, delete

			

 

	“Up to 2 years from Effective Date of this Agreement	25%
	Between 2 years, 1 day and 4 years from Effective Date	15%
	After 4 years from Effective Date 	10%”

         

and replace it with

 

	
			“For such consideration received, on a country by country basis, for clinical milestones and first commercial sale of each Licensed Product and Licensed Process

				10%
	 	 
	
			For all other such consideration received, on a country by country basis, for each Licensed Product and Licensed Process

				10%”

               

	
			2.

				
			In Section 3.1.2, delete the entire text and replace it with, “Licensee agrees that the first commercial sale of products to the retail customer shall occur on or before December 31, 2025, or UFRF shall have the right to terminate this Agreement pursuant to Section 9 .3 hereto.”

			

 

	
			3.

				
			Delete item (iv) in Section 4.4 and all references to item (iv) in section 4.4.

			

 

	
			4.

				
			In Section 4.4 of the License Agreement, delete

			

 

“Royalties are payable for the longer of (a) the last to expire of the claims in the Licensed Patents pursuant to sections (i) and (ii) above, or (b) ten (10) years from the first commercial sale of a Licensed Product or Licensed Process in each country in which the Licensed Product or Licensed Process is sold pursuant to section (iii) and (iv) above.”

 

 

 

 

and replace it with:

 

“Royalties are payable until the shorter of (a) ten (10) years from the first commercial sale of a Licensed Product or Licensed Process in each country in which the Licensed Product or Licensed Process is sold pursuant to section (iii) above; and (b) the expiration of the period of regulatory exclusivity for a Licensed Product on a country-by-country basis.”

 

	
			5.

				
			Delete Section 4.5 in its entirety.

			

 

	
			6.

				
			Delete Section 4.6 in its entirety.

			

 

	
			7.

				
			Delete “Appendix D – Milestones” in the table of Contents and delete Appendix D in its entirety.

			

 

	
			8.

				
			This amendment shall be effective on the date of the second signature below and shall be referred to as the Second Amendment.

			

 

UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.

 

By: ____________________________________

<name>

<title>

Date:___________________________________

 

 

SUN BIOPHARMA, INC.

 

By: ____________________________________

<name>

<title>

Date:___________________________________EX-4.1

 Exhibit 4.1 
  

					
	 NUMBER
  

*PRL1*
	  	DIGITAL REALTY TRUST, INC.	  	SHARES
	  

THIS CERTIFICATE IS TRANSFERABLE IN NEW YORK, N.Y.
	  	  
 INCORPORATED UNDER THE LAWS OF THE STATE OF
MARYLAND
	  	 SEE REVERSE FOR IMPORTANT NOTICE ON TRANSFER RESTRICTIONS

AND OTHER INFORMATION
  

CUSIP 253868 822

 THIS CERTIFIES THAT 

**SPECIMEN** 
 IS THE OWNER OF 

FULLY PAID AND NONASSESSABLE SHARES OF THE 5.200% SERIES L CUMULATIVE REDEEMABLE PREFERRED STOCK, PAR VALUE $0.01 PER SHARE, OF 

Digital Realty Trust, Inc. 
 (the
“Company”) transferable on the books of the Company by the holder hereof in person or by its duly authorized attorney, upon surrender of this Certificate properly endorsed. This Certificate is not valid unless countersigned by the Transfer
Agent and registered by the Registrar. 
 IN WITNESS WHEREOF, the Company has caused this Certificate to be executed on its behalf by its
duly authorized officers. 
 DATED
                     
  

							
	Countersigned and Registered:	 	American Stock Transfer & Trust Company, LLC	 	
		 	(New York, NY) Transfer Agent and Registrar	 	                                   
                               (SEAL)
	
	[Seal]
				
		 		 	        	 	                                   
                                         
  

  

			
	By:	 	
                     

		 	Authorized Signature

 DIGITAL REALTY TRUST, INC. 

IMPORTANT NOTICE 

Classes of Stock 
 THE
COMPANY IS AUTHORIZED TO ISSUE CAPITAL STOCK OF MORE THAN ONE CLASS, CONSISTING OF COMMON STOCK AND ONE OR MORE CLASSES OF PREFERRED STOCK. THE BOARD OF DIRECTORS IS AUTHORIZED TO DETERMINE THE PREFERENCES, LIMITATIONS AND RELATIVE RIGHTS OF ANY
CLASS OF THE PREFERRED STOCK BEFORE THE ISSUANCE OF SHARES OF SUCH CLASS OF PREFERRED STOCK. THE COMPANY WILL FURNISH, WITHOUT CHARGE, TO ANY STOCKHOLDER MAKING A WRITTEN REQUEST THEREFOR, A COPY OF THE COMPANY’S CHARTER AND A WRITTEN STATEMENT
OF THE DESIGNATIONS, RELATIVE RIGHTS, PREFERENCES, CONVERSION OR OTHER RIGHTS, VOTING POWERS, RESTRICTIONS, LIMITATIONS AS TO DIVIDENDS AND OTHER DISTRIBUTIONS, QUALIFICATIONS AND TERMS AND CONDITIONS OF REDEMPTION OF THE STOCK OF EACH CLASS WHICH
THE COMPANY HAS THE AUTHORITY TO ISSUE AND, IF THE COMPANY IS AUTHORIZED TO ISSUE ANY PREFERRED OR SPECIAL CLASS IN SERIES, (i) THE DIFFERENCES IN THE RELATIVE RIGHTS AND PREFERENCES BETWEEN THE SHARES OF EACH SERIES TO THE EXTENT SET, AND
(ii) THE AUTHORITY OF THE BOARD OF DIRECTORS TO SET SUCH RIGHTS AND PREFERENCES OF SUBSEQUENT SERIES. REQUESTS FOR SUCH WRITTEN STATEMENT MAY BE DIRECTED TO THE SECRETARY OF THE COMPANY AT ITS PRINCIPAL OFFICE. 

Restriction on Ownership and Transfer 

THE SHARES OF THE COMPANY’S 5.200% SERIES L CUMULATIVE REDEEMABLE PREFERRED STOCK (“SERIES L PREFERRED STOCK”) REPRESENTED BY
THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON BENEFICIAL AND CONSTRUCTIVE OWNERSHIP AND TRANSFER FOR THE PURPOSE OF THE COMPANY’S MAINTENANCE OF ITS STATUS AS A REAL ESTATE INVESTMENT TRUST UNDER THE INTERNAL REVENUE CODE OF 1986, AS AMENDED
(THE “CODE”). SUBJECT TO CERTAIN FURTHER RESTRICTIONS AND EXCEPT AS EXPRESSLY PROVIDED IN THE ARTICLES SUPPLEMENTARY FOR THE SERIES L PREFERRED STOCK, (i) NO PERSON MAY BENEFICIALLY OR CONSTRUCTIVELY OWN SHARES OF SERIES L PREFERRED
STOCK IN EXCESS OF 9.8% (BY VALUE OR BY NUMBER OF SHARES, WHICHEVER IS MORE RESTRICTIVE) OF THE OUTSTANDING SERIES L PREFERRED STOCK OF THE COMPANY; (ii) NO PERSON MAY BENEFICIALLY OR CONSTRUCTIVELY OWN SHARES OF SERIES L PREFERRED STOCK THAT,
TAKING INTO ACCOUNT ANY OTHER CAPITAL STOCK OF THE COMPANY BENEFICIALLY OR CONSTRUCTIVELY OWNED BY SUCH PERSON, WOULD RESULT IN SUCH PERSON BENEFICIALLY OR CONSTRUCTIVELY OWNING CAPITAL STOCK WITH A VALUE IN EXCESS OF 9.8% OF THE VALUE OF THE
COMPANY’S OUTSTANDING CAPITAL STOCK; (iii) NO PERSON MAY BENEFICIALLY OR CONSTRUCTIVELY OWN SHARES OF SERIES L PREFERRED STOCK THAT, TAKING INTO ACCOUNT ANY OTHER CAPITAL STOCK OF THE COMPANY BENEFICIALLY OR CONSTRUCTIVELY OWNED BY SUCH
PERSON, WOULD RESULT IN THE COMPANY BEING “CLOSELY HELD” UNDER SECTION 856(h) OF THE CODE OR OTHERWISE CAUSE THE COMPANY TO FAIL TO QUALIFY AS A REIT; AND (iv) ANY TRANSFER OF SHARES OF SERIES L PREFERRED STOCK THAT, IF EFFECTIVE,
WOULD RESULT IN THE CAPITAL STOCK OF THE COMPANY BEING BENEFICIALLY OWNED BY FEWER THAN 100 PERSONS WILL BE VOID AB INITIO AND THE INTENDED TRANSFEREE WILL ACQUIRE NO RIGHTS IN SUCH SHARES OF SERIES L PREFERRED STOCK. ANY PERSON WHO BENEFICIALLY OR
CONSTRUCTIVELY OWNS OR ATTEMPTS TO BENEFICIALLY OR CONSTRUCTIVELY OWN SERIES L PREFERRED STOCK WHICH CAUSES OR WILL CAUSE A PERSON TO BENEFICIALLY OR CONSTRUCTIVELY OWN SERIES L PREFERRED STOCK IN EXCESS OF THE ABOVE LIMITATIONS MUST IMMEDIATELY
NOTIFY THE COMPANY. IF ANY OF THE RESTRICTIONS ON TRANSFER OR OWNERSHIP IN (i) THROUGH (iii) ABOVE ARE VIOLATED, THE SERIES L PREFERRED STOCK REPRESENTED HEREBY IN EXCESS OF SUCH RESTRICTIONS WILL BE AUTOMATICALLY TRANSFERRED TO THE TRUSTEE OF
A TRUST FOR THE BENEFIT OF ONE OR MORE CHARITABLE BENEFICIARIES. IN ADDITION, THE COMPANY MAY REDEEM SHARES UPON THE TERMS AND CONDITIONS SPECIFIED BY THE BOARD OF DIRECTORS IN ITS SOLE DISCRETION IF THE BOARD OF DIRECTORS DETERMINES THAT OWNERSHIP
OR A TRANSFER OR OTHER EVENT MAY VIOLATE THE RESTRICTIONS DESCRIBED ABOVE. FURTHERMORE, UPON THE OCCURRENCE OF CERTAIN EVENTS, ATTEMPTED TRANSFERS IN VIOLATION OF THE RESTRICTIONS DESCRIBED ABOVE MAY BE VOID AB INITIO. ALL TERMS IN THIS LEGEND WHICH
ARE DEFINED IN THE ARTICLES SUPPLEMENTARY FOR THE SERIES L PREFERRED STOCK SHALL HAVE THE MEANINGS ASCRIBED TO THEM IN SUCH ARTICLES SUPPLEMENTARY, AS THE SAME MAY BE AMENDED FROM TIME TO TIME, A COPY OF WHICH, INCLUDING THE RESTRICTIONS ON TRANSFER
AND OWNERSHIP, WILL BE FURNISHED TO EACH HOLDER OF SERIES L PREFERRED STOCK ON REQUEST AND WITHOUT CHARGE. REQUESTS FOR SUCH A COPY MAY BE DIRECTED TO THE SECRETARY OF THE COMPANY AT ITS PRINCIPAL OFFICE. 

Keep this Certificate in a safe place. If it is lost, stolen, or destroyed, the Company will require a bond of indemnity as a condition to the
issuance of a replacement certificate. 
 
 The following
abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: 

 

											
		 	TEN COM	 	 -   as tenants in common
	 	UNIF GIFT MIN ACT	 	                            Custodian	 	
		 	TEN ENT	 	 -   as tenants by the entireties
	 		 	(Custodian)                              (Minor)	 	
		 	JT TEN	 	 -   as joint tenants with right of survivorship and not as tenants in
common
	 		 	under Uniform Gifts to Minors Act of	 	
		 		 		 		 	  
 (State)
	 	

 Additional abbreviations may also be used though not in the above list. 

FOR VALUE RECEIVED,
                                         
                    DOES HEREBY SELL, ASSIGN AND TRANSFER UNTO 

PLEASE INSERT SOCIAL SECURITY OR OTHER 

IDENTIFYING NUMBER OF ASSIGNEE 
  

					
	    	  	    	  	    

  
  

(Please Print or Typewrite Name and Address, Including Zip Code, of Assignee) 

 
  
  

 
  

 
 shares of the 5.200% Series L Cumulative Redeemable
Preferred Stock represented by the within Certificate and does hereby irrevocably constitute and appoint 
  

 
 to transfer the said stock on the books of the
within named Company with full power of substitution in the premises. 
 Dated
                     
  

			
	X	 	  

		
	X	 	  

		
	NOTICE:	 	THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAMES AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.

 Signature(s) Guaranteed 
  

			
	By	 	
                     

	THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM),
PURSUANT TO S.E.C. RULE 17Ad-15.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]